首页>
外国专利>
EXTENDED RISK ASSESSMENT PANEL FOR INDIVIDUALIZED TREATMENT OF CARDIOVASCULAR DISEASE, AND METHODS RELATED THERETO
EXTENDED RISK ASSESSMENT PANEL FOR INDIVIDUALIZED TREATMENT OF CARDIOVASCULAR DISEASE, AND METHODS RELATED THERETO
展开▼
机译:个性化治疗心血管疾病的扩展风险评估小组及其相关方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
Disclosed is a personalized diagnostic and treatment solution for cardiovascular disease. The invention comprises an extended CVD risk assessment panel, combining tests for traditional and new important risk markers, and methods for devising a personalized treatment plan for a patient via the use of a CVD diagnosis and treatment protocol algorithm. The new important risk markers include HDL subpopulation profile by two-dimensional gel-electrophoresis, plasma sterols, direct measurement of sdLDL-C, determination of CRP molecular forms, glycated albumin as a percentile of total albumin, and other specialized testing pertaining to apolipoprotein E and Factor V Leiden genotyping, NT-proBNP and adiponectin. This solution provides a more complete risk assessment of an individual than merely measuring traditional CVD risk markers, and enables the healthcare practitioner to optimize therapy for patients with or without established CVD. This solution presents the advantages of greater accuracy, savings in time and cost over existing testing and treatment methods.
展开▼